share_log
Reuters ·  Sep 3 19:00
Medicinova Announces Acceptance of Abstract Regarding Mn-166 (Ibudilast) in Combat-ALS Clinical Trial for Presentation at the 2024 Annual Neals (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment